CHUM — Centre hospitalier de l'Université de Montréal

Zusammenfassung

CHUM combines multidisciplinary oncology care with the diagnostic, surgical and supportive services of a major academic hospital. Areas of particular relevance include hepatobiliary care, transplant-related oncology expertise, immunotherapy and interventional radiology. Treatment planning may involve several specialists and should account for tumour stage, pathology, molecular findings, previous treatment and the patient's general health. The supplied profile indicates around 150 active oncology clinical trials, but this is an indicative figure rather than a verified current recruitment count. Patients travelling from abroad should obtain confirmation that CHUM can review their case before making arrangements. Financial responsibility, language assistance, the likely treatment schedule and follow-up in the home country also require advance clarification.

Das Wichtigste

CHUM is a public academic hospital in downtown Montreal, affiliated with the Université de Montréal.
Featured cancer programmes include liver, colorectal, lung, breast, and head and neck oncology.
Available modalities include surgery, radiation therapy, chemotherapy, immunotherapy and targeted therapy.
Hepatobiliary care, transplant-related oncology and interventional radiology are relevant areas of expertise.
Around 150 active oncology trials is an indicative portfolio figure, not a count of open places.
International patients need individual confirmation of referral acceptance, funding and treatment eligibility.

Überblick

CHUM was formed in 1996 through the merger of three Montreal hospitals: Hôtel-Dieu, Hôpital Notre-Dame and Hôpital Saint-Luc. Its modern downtown hospital complex began receiving patients in 2017. The institution is part of Quebec's public healthcare system and is affiliated with the Université de Montréal.

It is a large, multispecialty academic hospital rather than a stand-alone cancer clinic. Oncology patients may require input from imaging, pathology, surgery, medical oncology, radiation oncology and other hospital services. This broader hospital setting is relevant when cancer treatment involves complex operations, significant coexisting illness or specialist supportive care.

The Centre de recherche du CHUM, commonly called CRCHUM, supports research linked to clinical care, including cancer research. CHUM is known for hepatobiliary services and transplant expertise, alongside immunotherapy and interventional radiology programmes. These capabilities do not mean that every procedure is appropriate or accessible for every patient. In particular, access to transplantation has separate clinical and allocation requirements.

Schwerpunkte

The featured specialties are liver, colorectal, lung, breast, and head and neck cancers. Liver cancer assessment may involve hepatobiliary surgeons, hepatologists, oncologists and interventional radiologists. Decisions depend not only on the tumour but also on underlying liver function. Colorectal cancer care may require coordination between bowel surgery, systemic therapy and teams assessing disease that has spread to the liver.

For lung and breast cancers, pathology and biomarker testing can influence the choice between local and systemic treatment. Head and neck care often requires attention to speech, swallowing, nutrition and reconstruction as well as tumour control. The listed specialties describe programme areas, not comparative rankings or guaranteed outcomes. Patients with uncommon subtypes, recurrent disease or complex previous treatment should ask whether the relevant team can undertake a case review.

Verfügbare Behandlungen

Surgery is one of the treatment modalities offered, with the proposed operation depending on tumour location, extent and operability. Hepatobiliary expertise is particularly relevant to selected liver tumours and liver metastases. Transplant expertise should not be interpreted as routine transplantation for cancer: eligibility is highly selective, and access for non-residents requires explicit clarification.

Radiation therapy may be used with curative intent, alongside other treatments or to relieve symptoms. Chemotherapy, immunotherapy and targeted therapy are also available modalities. Their suitability depends on the specific diagnosis, biomarkers, previous therapies, organ function and applicable treatment approvals. Availability of a drug or programme does not establish that it will be recommended or funded for an international patient.

Interventional radiology may contribute to image-guided diagnosis and selected local treatments, such as ablation or catheter-directed procedures. Patients should confirm the exact techniques offered for their condition. Clinical trials can provide another treatment pathway for eligible participants, but research treatment is not automatically preferable to standard care. Ask how symptom management, rehabilitation and palliative care would be integrated into the proposed plan.

Klinische Studien

The supplied profile describes around 150 active oncology clinical trials at CHUM. This number is indicative and should not be treated as a verified current total. Trial portfolios change, and an active study may be following existing participants rather than recruiting new ones. The CRCHUM research environment supports oncology research, but the availability of a suitable study must be checked by diagnosis and protocol.

International patients can ask the relevant clinical team whether a trial review is possible and whether a particular study accepts participants residing abroad. Screening can require pathology confirmation, molecular results, assessment of previous treatments and additional investigations. Eligibility also depends on health status and protocol-specific criteria. Before travelling, clarify visit frequency, research consent, treatment-related costs, non-research expenses and arrangements for urgent care. A preliminary discussion does not guarantee enrolment.

Praktische Hinweise für internationale Patientinnen und Patienten

Begin by asking CHUM's official channels how an overseas oncology referral should be submitted. Provide a concise clinical summary and ask which service should receive it. Do not assume that Quebec public coverage applies to visitors. Obtain written clarification of administrative acceptance, financial arrangements and whether an initial records review can occur before travel.

If an appointment is offered, request a provisional schedule that distinguishes assessment from confirmed treatment. Discuss fitness to fly, the need for a companion and possible extensions to the stay. Establish who will manage complications and how reports, prescriptions and follow-up instructions will reach the treating team at home. Travel plans should remain flexible until the clinical pathway is agreed.

Kontaktinformationen

Contact details below come from the hospital's own published international patient information.

Location: Montreal, Canada

Email: No public international e-mail address is published; use the website enquiry form.

Phone: +1 514 890 8000

Website: https://www.chumontreal.qc.ca

Languages supported: French, English

Remote second opinion: Not advertised

Always confirm current contact details on the hospital's own website before sending medical records, and never send documents to an address you have not verified.

Fragen von Patientinnen und Patienten

Will you accept an overseas referral for my diagnosis and previous treatment history?
Can your team review my records before I travel?
Which pathology materials, scans and translations do you require?
What treatment would you recommend, and what alternatives could I receive at home?
Is a relevant trial recruiting, and can non-residents participate?
What costs, deposits and insurance authorisations should I arrange?
Can you provide language assistance for consultations and consent?
How long might I need to remain locally, and who will coordinate follow-up?

Häufige Fragen

How does an international patient start the referral process?

Use CHUM's official website to identify the appropriate route for asking about an oncology referral from abroad. Explain the diagnosis, current country of residence and purpose of the request, such as a second opinion or treatment assessment. Ask whether a referral from the treating physician is required and whether records can be reviewed remotely. Clinical acceptance, administrative approval and payment arrangements may be separate steps. Avoid booking travel until the hospital has confirmed what appointment or assessment it can offer.

Which medical records should I prepare?

Prepare a chronological treatment summary, pathology reports, operation reports, recent clinic letters, imaging reports and the actual scan files where available. Include chemotherapy and other drug names, treatment dates, radiation details, molecular test results, current medicines and allergies. The reviewing team may also request pathology slides or tissue blocks. Ask which file formats and languages are accepted and whether professional translations are needed. Send identifiable medical information only through a submission route confirmed by the hospital.

What should I expect regarding costs and insurance?

Do not assume that treatment is free for an international visitor because CHUM is a public hospital. Responsibility for consultation, investigations, procedures, medicines and hospital care depends on eligibility and payment arrangements. Request an individual written estimate and ask what it excludes, including complications, repeat tests and additional stays. Confirm any insurer authorisation or deposit requirements directly. Trial participation does not necessarily cover routine care, travel or accommodation; research-funded and patient-funded items should be explained separately.

What language support should I arrange?

CHUM operates in a predominantly French-speaking healthcare environment. If you need consultations, written information or consent discussions in another language, ask about support before the appointment. English communication may be possible, but availability should not be assumed for every service or encounter. Confirm whether professional interpreting can be arranged, who pays for it and whether translated records are required. A companion can provide support, but should not be relied upon as the sole interpreter for complex medical decisions.

How should I plan travel and accommodation?

Plan accommodation only after confirming the expected appointment sequence and whether treatment is likely to be outpatient or require admission. Ask how close you should remain to the hospital, whether a caregiver is necessary and whether there are accommodation information services. Do not assume lodging or airport transfers are provided. Discuss fitness to fly, entry requirements and insurance that covers the planned care. Allow for changes caused by additional tests, recovery or complications, and agree on follow-up arrangements before returning home.

Quellen

1.CHUM official website — hospital, care and research information— Centre hospitalier de l'Université de Montréal
2.National Cancer Institute — general cancer treatment and clinical trial information— National Cancer Institute
3.ESMO — general oncology guidance and patient resources— European Society for Medical Oncology

GetOnco AI fragen

Erhalten Sie persönliche Antworten zu „CHUM — Centre hospitalier de l'Université de Montréal | Cancer“ von Ihrem KI-Koordinator für Krebsversorgung.

GetOnco AI liefert Informationen zu Bildungszwecken und ersetzt niemals den Rat Ihres Behandlungsteams.

CHUM — Centre hospitalier de l'Université de Montréal | Cancer